More on CYDY
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $0.27 |
|
|||
| Open | $0.28 | ||||
| 52 Wk High | $1.57 | ||||
| 52 Wk Low | $0.61 | ||||
| Day High | $0.28 | ||||
| Day Low | $0.26 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 1,841,923 | ||||
- Natera partners with CytoDyn for colorectal cancer drug development
- Natera and CytoDyn Announce Strategic Collaboration to Advance ctDNA-Guided Development and Molecular Response Analysis in Metastatic Colorectal Cancer
- Form EFFECT CytoDyn Inc.
- Form 424B3 CytoDyn Inc.
- CytoDyn to Present at the LD Micro Invitational XVI
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities
- Form D CytoDyn Inc.
- Form 8-K CytoDyn Inc. For: Apr 30
- CytoDyn Announces First Patient Dosed in Expanded Access Program for Leronlimab in Triple-Negative Breast Cancer
- CytoDyn to Host Investor Webcast
Entities mentioned with CYDY
- FDA | View Related Stories »
- Definitive Agreement | View Related Stories »
- PDUFA | View Related Stories »
- S3 | View Related Stories »
- 13D | View Related Stories »
- S1 | View Related Stories »
- H.C. Wainwright | View Related Stories »
- Sanford C. Bernstein | View Related Stories »
- Show More...
